Chemokines in cancer

被引:315
作者
Vicari, AP [1 ]
Caux, C [1 ]
机构
[1] Schering Plough Corp, Lab Immunol Res, F-69571 Dardilly, France
关键词
cancer; chemokine; angiogenesis; metastasis; macrophage; dendritic cell; T cell;
D O I
10.1016/S1359-6101(01)00033-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines participate, by regulating cell trafficking and controlling angiogenesis, in the host response during infection and inflammation. Most of these mechanisms are also operating in cancer. The stimulation of angiogenesis and tumor growth-directly or indirectly through the recruitment of tumor-associated macrophages-are typical situations where chemokines promote tumor development. On the other hand, chemokines could be used to the benefit of cancer patients as they act in the recruitment of dendritic cells (DC) or/and effector cells or for their angiostatic properties. However, chemokine-mediated recruitment of immature DC within tumors, due to factors produced by the tumor milieu, could lead to the induction of immune tolerance and, therefore, novel strategies to eradicate tumors based on chemokines should attempt to avoid this risk. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:143 / 154
页数:12
相关论文
共 168 条
[61]   Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells [J].
Iwasaki, A ;
Kelsall, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) :229-239
[62]  
Jonjic N, 1998, ANTICANCER RES, V18, P3767
[63]   Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells [J].
Jonuleit, H ;
Schmitt, E ;
Schuler, G ;
Knop, J ;
Enk, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (09) :1213-1222
[64]   Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type IIFN [J].
Kadowaki, N ;
Antonenko, S ;
Liu, YJ .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2291-2295
[65]   T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal [J].
Kalinski, P ;
Hilkens, CMU ;
Wierenga, EA ;
Kapsenberg, ML .
IMMUNOLOGY TODAY, 1999, 20 (12) :561-567
[66]  
Kalinski P, 1998, J IMMUNOL, V161, P2804
[67]   CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKβ-11/MIP-3β/ELC, are chemoattractants for CD56+CD16- NK cells and late stage lymphoid progenitors [J].
Kim, CH ;
Pelus, LM ;
Appelbaum, E ;
Johanson, K ;
Anzai, N ;
Broxmeyer, HE .
CELLULAR IMMUNOLOGY, 1999, 193 (02) :226-235
[68]  
Kirk CJ, 2001, CANCER RES, V61, P2062
[69]   Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group trial EST 1684 [J].
Kirkwood, JM ;
Strawderman, MH ;
Ernstoff, MS ;
Smith, TJ ;
Borden, EC ;
Blum, RH .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :7-17
[70]  
Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO